
Understanding Reasons for Greater Disability, Loss of Deep Gray Matter in Latinx Patients With MS: Daniel Ontaneda, MD, PhD
The associate professor of neurology at the Cleveland Clinic Lerner College of Medicine of Case Western University discussed a presentation at AAN 2023 characterizing the clinical and MRI features of Latinx with multiple sclerosis. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes
Multiple sclerosis (MS) is a genetically complex autoimmune disease with an incidence and prevalence that is reported to differ with race and ethnicity. To gain a better understanding of how the disease affects Latinx patients, a group of investigators conducted a retrospective, cross-sectional study using individuals from the MS PATHS network. The analysis included 388 Latinx and 5726 White patients who underwent brain MRI within 1 year of clinical testing, with comparisons made through 2-sample t-test and Wilcoxon rank-sum.
Despite Latinx patients being younger (45.4 years vs 52.9 years; P <.001) and having shorter disease duration (17.2 years vs 19.5 years; P <.001), these individuals had higher T2 lesions volume (8.0 ml vs 6.5 ml; P = .009) and lower thalamic volume (12.8 ml vs 13.3 ml; P <.001) compared with White individuals. Led by
Ontaneda, an associate professor of neurology at the Cleveland Clinic Lerner College of Medicine of Case Western University, believes these findings are significant, especially considering that Latinx individuals were younger and had shorter disease duration. At the












